Home ENYO Pharma

ENYO Pharma

ENYO Pharma

ENYO Pharma
Category
Business Description
ENYO Pharma is a clinical-stage firm with a unique virus-inspired approach. With many applications, our biotech mimics virus technique to alter host cellular activities.
Infectious disorders (e.g. HBV), metabolic diseases (e.g. NASH), and oncology are among the indications in which we investigate new therapeutic candidates.
Vonafexor (EYP001, FXR agonist), our lead candidate, is in Phase 2 for chronic hepatitis B and non-alcoholic steato-hepatitis. EYP002, our second candidate, is currently undergoing preclinical testing. It was originally created to combat the influenza virus, but because it has a mitochondrial cellular target, ENYO Pharma is looking into other indications such as oncology and metabolic illnesses.
Based in
Lyon
Tags
Biopharma, Biotechnology, Medical
Total Funding
Above €25 million
Founded
2014
Website
http://www.enyopharma.com/

Articles about ENYO Pharma:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as ENYO Pharma? We're happy to assist you with our Startup Sourcing service.